摘要
银杏叶制剂每次2片(40mg/片),tid,po,疗程1mo,治疗冠心病284例,男性153例,女性13例,年龄60.2±s1.4a,缓解心绞痛总有效率为90.1%,显效率为62.2%。缺血性心电图的总好转率为77.6%,明显降低TG和TC,提高HDL-ch水平,与治疗前比,P均<0.01,并能明显改善血液流变学、降低LPO和提高SOD活力的作用。
Two hunder and eight-four patients( M 153,F131,age 60.2±s 1.4 a)with coronary heart disease were treated with Ginkgo biloba leaves proparation(GBLP)80 mg(40mg/tablet),po tid.After one month,the clinical total effective rate for the patients with angina pectoris was 90.1%,marked effective rate was 62.2%; total effective rate for the patitents with ischemic electrocardiogram change was 77.6%, It could regulate lipid, such as decreased TG,TC and increase HDL-ch;their total improvement rate were 47.1%,52.5%,and 63.9%,respectively; after administation of GBLP, the results showed that differenee of effect was significant(P<0.01).Moreover it could improve blood viscosity,decrease LPO and increase E-SOD.
出处
《新药与临床》
CSCD
北大核心
1995年第3期151-154,共4页
关键词
银杏叶制剂
血液粘度
冠心病
超氧化物歧化酶
Ginkgo biloba leave preparation
coronary disease
hyperlipidemia
blood viscosity
lipid peroxides
superoxide dismutase